Your browser doesn't support javascript.
loading
Report of the European Medicines Agency Conference on RNA-Based Medicines.
Ehmann, Falk; Kuhn, Andreas; Pasmooij, Anna Maria Gerdina; Humphreys, Anthony; Van Hengel, Arjon; Dooley, Brian; Anliker, Brigitte; Svensson, Camilla; Capaldi, Daniel; Henshall, David; Cooke, Emer; Zhou, Haiyan; Bastaerts, Hilde; Smink, Jeske; Van Gerven, Joop; Enes, Leonor; Nechev, Lubomir; Hoefnagel, Marcel; Driessens, Mariëtte; Wenger, Michael; Blanquie, Oriane; Widomski, Pawel; Herold, Ralf; Thürmer, René; Ruiz, Sol; Thirstrup, Steffen; Goody, Susan; Zaks, Tal; Cordò, Valentina; Aartsma-Rus, Annemieke M.
Afiliación
  • Ehmann F; European Medicines Agency, Amsterdam, The Netherlands.
  • Kuhn A; BioNTech SE, Mainz, Germany.
  • Pasmooij AMG; Medicines Evaluation Board (MEB), Utrecht, The Netherlands.
  • Humphreys A; European Medicines Agency, Amsterdam, The Netherlands.
  • Van Hengel A; DG Research and Innovation, European Commission, Brussels, Belgium.
  • Dooley B; European Medicines Agency, Amsterdam, The Netherlands.
  • Anliker B; Paul Ehrlich Institute (PEI), Langen, Germany.
  • Svensson C; Medical Products Agency (MPA), Uppsala, Sweden.
  • Capaldi D; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA.
  • Henshall D; RCSI University of Medicine and Health Sciences College of Surgeons RCSI and FutureNeuro SFI Research Centre, Dublin, Ireland.
  • Cooke E; European Medicines Agency, Amsterdam, The Netherlands.
  • Zhou H; University College London (UCL), NIHR Great Ormond Street Hospital Biomedical Research Centre, London, United Kingdom.
  • Bastaerts H; European Medicines Agency, Amsterdam, The Netherlands.
  • Smink J; Silence Therapeutics GmbH, Berlin, Germany.
  • Van Gerven J; Central Committee on Research Involving Human Subjects (CCMO), The Hague, The Netherlands.
  • Enes L; European Medicines Agency, Amsterdam, The Netherlands.
  • Nechev L; Alnylam Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.
  • Hoefnagel M; Medicines Evaluation Board (MEB), Utrecht, The Netherlands.
  • Driessens M; VSOP - Patient Alliance for Rare and Genetic Diseases, Soest, The Netherlands.
  • Wenger M; BioNTech SE, Mainz, Germany.
  • Blanquie O; European Medicines Agency, Amsterdam, The Netherlands.
  • Widomski P; Department of Dermatology, University Medical Center of the Johannes Gutenberg-University Mainz, Germany.
  • Herold R; BioNTech SE, Mainz, Germany.
  • Thürmer R; European Medicines Agency, Amsterdam, The Netherlands.
  • Ruiz S; Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.
  • Thirstrup S; Agency of Medicines and Medical Products (AEMPS), Madrid, Spain.
  • Goody S; European Medicines Agency, Amsterdam, The Netherlands.
  • Zaks T; ModernaCambridge, Massachusetts, USA.
  • Cordò V; OrbiMed, Boston, Massachusetts, USA.
  • Aartsma-Rus AM; European Medicines Agency, Amsterdam, The Netherlands.
Nucleic Acid Ther ; 34(1): 4-11, 2024 02.
Article en En | MEDLINE | ID: mdl-38174996
ABSTRACT
RNA-based medicines have potential to treat a large variety of diseases, and research in the field is very dynamic. Proactively, The European Medicines Agency (EMA) organized a virtual conference on February 2, 2023 to promote the development of RNA-based medicines. The initiative addresses the goal of the EMA Regulatory Science Strategy to 2025 to "catalyse the integration of science and technology in medicines development." The conference focused on RNA technologies (excluding RNA vaccines) and involved different stakeholders, including representatives from academia, industry, regulatory authorities, and patient organizations. The conference comprised presentations and discussion sessions conducted by panels of subject matter experts. In this meeting report, we summarize the presentations and recap the main themes of the panel discussions.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ARN Límite: Humans Idioma: En Revista: Nucleic Acid Ther Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ARN Límite: Humans Idioma: En Revista: Nucleic Acid Ther Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos